iMSynP

iMSynP

亿纳谱

iMSynP

Biotech/Healthcare

Yinapu is a developer of molecular diagnostics products — a mass-spectrometry testing company built around its original nano-chip analysis system. By combining its independently designed and developed nano-chips with artificial intelligence, it has created a major-disease molecular-omics…

Latest round: Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-03-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.